Sichuan Biokin Pharmaceutical Co Ltd

CN

Health Care

122.31 ₽

Current price

Strong sell
122.31 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    1303 / 1328

  • Position in country

    7323 / 7387

  • Return on Assets, %

    -33.4

    -2.7

  • Net income margin, %

    -105.6

    2.8

  • EBITDA margin, %

    -96.4

    10.8

  • Debt to Equity, %

    129.9

    19.2

  • Intangible assets and goodwill, %

    2.4

    3.6

  • Revenue CAGR 3Y, %

    -16.5

    8.5

  • Total Equity change 1Y, %

    -57.9

    0

  • Revenue Y, % chg

    -17.7

    0.5

  • P/BV

    125.5

    1.5

  • P/S

    87

    2.3

  • EV/S

    87.2

    2.4

Get an analytical review of this company

Competitors

Ranks

  • China Resources Sanjiu Medical & Pharmaceutical Co Ltd

    00%

  • CSPC Pharmaceutical Group Ltd

    00%

  • Zhangzhou Pientzehuang Pharmaceutical Co Ltd

    00%

  • Beijing Tongrentang Co Ltd

    00%

  • Yunnan Baiyao Group Co Ltd

    00%

  • Hansoh Pharmaceutical Group Company Ltd

    00%

  • Zhejiang Nhu Co Ltd

    00%

  • Jiangsu Hengrui Pharmaceuticals Co Ltd

    00%

  • Shanghai Fosun Pharmaceutical Group Co Ltd

    00%

  • Sichuan Biokin Pharmaceutical Co Ltd

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    China

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Pharmaceuticals

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    7224

  • Ticker

    688506.SS

  • ISIN

    CNE100006FN4

  • IPO date

    2023-01-06

  • Availability on Russian exchanges

    No

  • Reporting for

    2023-08-30

  • Date fact. publication of reports

    2023-06-30

Company Description

PT Bumi Resources Minerals Tbk is an Indonesia-based Company engaged in mining business. The Company, through its subsidiaries, holds a diversified minerals assets and is engaged in the exploration and development of mining sites for minerals. Its products include copper, gold, zinc, lead, iron ore, diamond and other precious metals within the regions of Indonesia and West Africa. The Company's subsidiaries include PT International Minerals Company LLC, Bumi Resources Japan Company Limited, Calipso Investment Pte. Ltd., PT Multi Capital, PT Citra Palu Minerals, Sahara Resources Pte, Ltd. and Lemington Investment Pte. Ltd.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: